Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Vaccine
|
January 18, 2003
Two years into reverse vaccinology
Jeannette Adu-Bobie, Barbara Capecchi, Davide Serruto, et al.
Current Issues in Molecular Biology
|
November 25, 2003
The genome revolution in vaccine research
Barbara Capecchi, Davide Serruto, Jeannette Adu-Bobie, et al.
Trends in Biotechnology
|
January 22, 2005
The impact of genomics on vaccine design
Maria Scarselli, Marzia M Giuliani, Jeannette Adu-Bobie, et al.
Journal of Biotechnology
|
September 24, 2004
Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens
Davide Serruto, Jeannette Adu-Bobie, Barbara Capecchi, et al.
Molecular Microbiology
|
April 5, 2003
Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity
Davide Serruto, Jeannette Adu-Bobie, Maria Scarselli, et al.
The Journal of Infectious Diseases
|
November 26, 2003
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
Jo Anne Welsch, Gregory R Moe, Raffaella Rossi, et al.
Infection and Immunity
|
March 25, 2004
GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence
Jeannette Adu-Bobie, Pietro Lupetti, Brunella Brunelli, et al.
Molecular Microbiology
|
June 29, 2006
Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesin
Maria Scarselli, Davide Serruto, Paolo Montanari, et al.
Molecular Microbiology
|
January 22, 2005
Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells
Barbara Capecchi, Jeannette Adu-Bobie, Federica Di Marcello, et al.
Vaccine
|
January 14, 2010
Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection
Kate L Seib, Francesca Oriente, Jeannette Adu-Bobie, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Vaccine
|
January 18, 2003
Two years into reverse vaccinology
Jeannette Adu-Bobie, Barbara Capecchi, Davide Serruto, et al.
Current Issues in Molecular Biology
|
November 25, 2003
The genome revolution in vaccine research
Barbara Capecchi, Davide Serruto, Jeannette Adu-Bobie, et al.
Trends in Biotechnology
|
January 22, 2005
The impact of genomics on vaccine design
Maria Scarselli, Marzia M Giuliani, Jeannette Adu-Bobie, et al.
Journal of Biotechnology
|
September 24, 2004
Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens
Davide Serruto, Jeannette Adu-Bobie, Barbara Capecchi, et al.
Molecular Microbiology
|
April 5, 2003
Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity
Davide Serruto, Jeannette Adu-Bobie, Maria Scarselli, et al.
The Journal of Infectious Diseases
|
November 26, 2003
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
Jo Anne Welsch, Gregory R Moe, Raffaella Rossi, et al.
Infection and Immunity
|
March 25, 2004
GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence
Jeannette Adu-Bobie, Pietro Lupetti, Brunella Brunelli, et al.
Molecular Microbiology
|
June 29, 2006
Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesin
Maria Scarselli, Davide Serruto, Paolo Montanari, et al.
Molecular Microbiology
|
January 22, 2005
Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells
Barbara Capecchi, Jeannette Adu-Bobie, Federica Di Marcello, et al.
Vaccine
|
January 14, 2010
Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection
Kate L Seib, Francesca Oriente, Jeannette Adu-Bobie, et al.
Page
of 2